Common vitamin tested as potential Alzheimer's fighter
NCT ID NCT06582706
Summary
This study is testing if a common B-vitamin called niacin can get into the brain and spinal fluid of people with Alzheimer's disease. Researchers will give 30 participants either a 500mg niacin pill or a placebo (sugar pill) for 60 days. The main goal is to measure how much niacin reaches the brain and to check if it is safe, not to treat symptoms directly.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IU Health Neuroscience Center
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.